died in the imipenem/cilastatin group. This study prompted the FDA to issue a warning in September this year for the increased mortality associated with tigecycline in patients with severe infections.

The first application is for the company’s combination of relebactam, an investigational beta-lactamase inhibitor, with imipenem/cilastatin (MK-7655A, IMI/REL), for the treatment of complicated ...

The Units for debt settlement is subject to final TSX Venture Exchange (TSXV) approval. The holder of the Notes is an arms-length party to the Company. The Units were issued subject to prospectus ...

MSD took a similar approach with its Recarbrio (imipenem/cilastatin-relebactam) product, which was approved by the FDA for cUTIs and complicated intra-abdominal infections (cIAI) in 2019.

Medindia neither buys nor sells drugs. Imipenem and Cilastatin (Ime -Cila 500) is a broad spectrum beta-lactam antibiotic, prescribed for severe body infections.Cilastatin helps Imipenem work more ...

Furthermore, meropenem is administered less frequently than imipenem-cilastatin and may be associated with a lower frequency of gastrointestinal adverse effects. [1] Generally, carbapenems have ...

Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has arranged a non-brokered private placement offering of 290,323 common shares priced at $1.55 ...

New Data to be Presented at IDWeek 2024 Reinforce Merck’s Broad and Diverse Vaccines and Infectious Disease Pipeline and ...

TORONTO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has arranged a non-brokered private ...